Healthcare · Drug Manufacturers General · NYSE
| Market cap | $174.02B |
|---|---|
| Trailing P/E | 11.0 |
| FCF yield | 2.5% |
| Revenue growth (YoY) | +6.4% |
| EPS growth (YoY) | +1.8% |
| FCF/share growth (YoY) | -58.2% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Novo Nordisk A/S trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Scott Scott Franklin | House | Buy | $1,001 - $15,000 | Sep 17, 2026 |
| Alan Armstrong | Senate | Buy | $15,001 - $50,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $15,001 - $50,000 | Jul 21, 2026 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Oct 22, 2025 |
| Marjorie Taylor Greene | House | Buy | $1,001 - $15,000 | Oct 20, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Sep 12, 2025 |
| Valerie Hoyle | House | Buy | $1,001 - $15,000 | Sep 12, 2025 |
| Marjorie Taylor Greene | House | Buy | $1,001 - $15,000 | Aug 29, 2025 |
| Marjorie Taylor Greene | House | Buy | $15,001 - $50,000 | Aug 20, 2025 |
| Scott Scott Franklin | House | Buy | $1,001 - $15,000 | Aug 14, 2025 |